Detalhe da pesquisa
1.
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.
Nature
; 606(7915): 797-803, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35705814
2.
Author Correction: Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.
Nature
; 613(7945): E3, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36627494
3.
Comparative Bioavailability of a Single Dose of Trametinib (TMT212) Containing 9% vs 11% Dimethyl Sulfoxide in Randomized Healthy Volunteers to Assess Long-Term Storage at Room Temperature.
Clin Pharmacol Drug Dev
; 11(10): 1203-1210, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35736001
4.
Common envelope binary interaction simulations between a thermally pulsating AGB star and a low mass companion.
Mon Not R Astron Soc
; 517(3): 3181-3199, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36311180
5.
Understanding the Lived Experiences of Patients With Melanoma: Real-World Evidence Generated Through a European Social Media Listening Analysis.
JMIR Cancer
; 8(2): e35930, 2022 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35699985
6.
Improved pyrexia-related outcomes associated with an adapted pyrexia adverse event management algorithm in patients treated with adjuvant dabrafenib plus trametinib: Primary results of COMBI-APlus.
Eur J Cancer
; 163: 79-87, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35042070
7.
Pyrexia in patients treated with dabrafenib plus trametinib across clinical trials in BRAF-mutant cancers.
Eur J Cancer
; 153: 234-241, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34225229
8.
Dabrafenib plus trametinib is effective in the treatment of BRAF V600-mutated metastatic melanoma patients: analysis of patients from the dabrafenib plus trametinib Named Patient Program (DESCRIBE II).
Melanoma Res
; 30(3): 261-267, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31895752
9.
Effectiveness of dabrafenib in the treatment of patients with BRAF V600-mutated metastatic melanoma in a Named Patient Program.
Melanoma Res
; 29(5): 527-532, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31095039
10.
Phase I Study of Lapatinib and Pemetrexed in the Second-Line Treatment of Advanced or Metastatic Non-Small-Cell Lung Cancer With Assessment of Circulating Cell Free Thymidylate Synthase RNA as a Potential Biomarker.
Clin Lung Cancer
; 16(5): 348-57, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25700774
11.
Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancer.
EJNMMI Res
; 5: 30, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25977884
12.
Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: rationale for future randomised trials in human papilloma virus-negative disease.
Eur J Cancer
; 49(7): 1609-18, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23265705
13.
Erratum to: Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancer.
EJNMMI Res
; 7(1): 74, 2017 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28887806
14.
Amplification of epidermal growth factor receptor gene in renal cell carcinoma.
Eur J Cancer
; 46(5): 859-62, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20167476